These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

429 related items for PubMed ID: 18387351

  • 1. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
    McManus JF, Davey RA, Maclean HE, Doust EA, Chiu WS, Sims NA, Bouxsein ML, Glatt V, Zajac JD, Danks JA.
    Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
    [Abstract] [Full Text] [Related]

  • 2. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE, Yao W, Kinney JH, Modin G, Balooch M, Wronski TJ.
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY.
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [Abstract] [Full Text] [Related]

  • 6. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT, Samnegård E, Cullen DM, Kimmel DB.
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [Abstract] [Full Text] [Related]

  • 7. Effect of intermittent injection of recombinant human parathyroid hormone on bone histomorphometry of ovariectomized rats.
    Zhang KQ, Chen JW, Li QN, Li GF, Tian XY, Huang LF, Bao LH, Wang ML.
    Acta Pharmacol Sin; 2002 Jul; 23(7):659-62. PubMed ID: 12100763
    [Abstract] [Full Text] [Related]

  • 8. Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats.
    Ma YF, Jee WS, Ke HZ, Lin BY, Liang XG, Li M, Yamamoto N.
    J Bone Miner Res; 1995 Mar; 10(3):496-505. PubMed ID: 7785472
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
    Iida-Klein A, Lu SS, Cosman F, Lindsay R, Dempster DW.
    Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
    [Abstract] [Full Text] [Related]

  • 11. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.
    Kimmel DB, Bozzato RP, Kronis KA, Coble T, Sindrey D, Kwong P, Recker RR.
    Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456
    [Abstract] [Full Text] [Related]

  • 12. Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats.
    Nozaka K, Miyakoshi N, Kasukawa Y, Maekawa S, Noguchi H, Shimada Y.
    Bone; 2008 Jan; 42(1):90-7. PubMed ID: 17997377
    [Abstract] [Full Text] [Related]

  • 13. Anabolic effects of recombinant human parathyroid hormone (1 - 84) and synthetic human parathyroid hormone (1 - 34) on the mandibles of osteopenic ovariectomized rats with maxillary molar extraction.
    Kawane T, Takahashi S, Saitoh H, Okamoto H, Kubodera N, Horiuchi N.
    Horm Metab Res; 2002 Jun; 34(6):293-302. PubMed ID: 12173069
    [Abstract] [Full Text] [Related]

  • 14. Cyclical treatment of osteopenic ovariectomized adult rats with PTH(1-34) and pamidronate.
    Cheng PT, Chan C, Müller K.
    J Bone Miner Res; 1995 Jan; 10(1):119-26. PubMed ID: 7747618
    [Abstract] [Full Text] [Related]

  • 15. Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase.
    Rixon RH, Whitfield JF, Gagnon L, Isaacs RJ, Maclean S, Chakravarthy B, Durkin JP, Neugebauer W, Ross V, Sung W.
    J Bone Miner Res; 1994 Aug; 9(8):1179-89. PubMed ID: 7976500
    [Abstract] [Full Text] [Related]

  • 16. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
    Pierroz DD, Bouxsein ML, Rizzoli R, Ferrari SL.
    Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
    [Abstract] [Full Text] [Related]

  • 17. Parathyroid hormone 1-34 enhances titanium implant anchorage in low-density trabecular bone: a correlative micro-computed tomographic and biomechanical analysis.
    Gabet Y, Müller R, Levy J, Dimarchi R, Chorev M, Bab I, Kohavi D.
    Bone; 2006 Aug; 39(2):276-82. PubMed ID: 16617039
    [Abstract] [Full Text] [Related]

  • 18. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
    Oxlund H, Ortoft G, Thomsen JS, Danielsen CC, Ejersted C, Andreassen TT.
    Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
    [Abstract] [Full Text] [Related]

  • 19. Effects of tiludronate on bone mass, structure, and turnover at the epiphyseal, primary, and secondary spongiosa in the proximal tibia of growing rats after sciatic neurectomy.
    Murakami H, Nakamura T, Tsurukami H, Abe M, Barbier A, Suzuki K.
    J Bone Miner Res; 1994 Sep; 9(9):1355-64. PubMed ID: 7529459
    [Abstract] [Full Text] [Related]

  • 20. Human parathyroid hormone 1-34 prevents bone loss in experimental biliary cirrhosis in rats.
    Dresner-Pollak R, Gabet Y, Steimatzky A, Hamdani G, Bab I, Ackerman Z, Weinreb M.
    Gastroenterology; 2008 Jan; 134(1):259-67. PubMed ID: 18061175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.